Good find@Khool!!!There's some things we can take from this...

Good find@Khool!!!

There's some things we can take from this registration announcement:

• We could be wrong, but this appears to be the factorial 2B trial -- an extension/ more robust version of the current OSA 2B trial. After the results of the factorial trial, we can move towards a phase 3 trial and will be probably capped at above a billion dollars considering OSA has no current treatments and is a billion dollar market. This valuation is for OSA alone, mind you. Imagine the market cap when you include the other trials, and as things take off with them as well.
• We like hearing that patients who already had success with the treatments will take part in the trial. This serves the company well in two ways: 1) it reduces time and a need to find more patients; 2) those who had success with our OSA product, theoretically, should continue to have more success with our product. This is good news because it should lead to more positive news and, secondly, if the patients find they don't need to say our OSA pill in a couple of months time and are fully treated, our OSA pill could end up becoming a cure for sleep apnoea! (Imagine what this would do for the share price!)
• We like that its over a period of six months because that's long enough to see if the pill works. In fact, if we hear positive news from this current OSA phase 2B trial, we should already know if it works.

The sheer fact that management are planning an OSA extension screams success of the current 2B OSA trial. Why would you do an extension if the OSA pill didn't work and, secondly, use sentences like "this will enable participants who has an OVERALL REDUCTION in OSA to cont...."

Mark our words: as our research suggested in January on our blog, this is a slam dunk trial!

Keep in mind, IHL has far more going than OSA...

The Nasdaq listing flagged on this forum to happen around Sept (@DaveFisher) could literally send the share price to the moon. The smart money really take notice of Nasdaq listings and the fact that we have this OSA drug in the works (looking like a major success), and 2 potential psychedelics trials kicking off + more happening, it screams a billion dollar-plus market cap coming to a screen near you soon.

We're super excited for the new financial year, especially the second half of this calendar year. We betting that IHL makes multiple new millionaires and set's many shareholders up for life!
To your first million,
-Trading For Millions